d) – Westösterreich (Salzburg, Tirol, Vorarlberg) at Bristol-Myers Squibb

Vienna, Vienna, Austria

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Healthcare, OncologyIndustries

Requirements

Certified Pharma Representative (Pharmareferentenprüfung) or any study that replaces the exam
Several years of experience in pharmaceutical industry in customer-facing commercial field roles
Strong preference for knowledge and experience in Oncology
Fluent in German and English

Responsibilities

Sales force activities for the assigned region with focus on our Oncology portfolio
Drives initiatives to grow the existing business and successfully launch new products, closely aligned with the cross-functional Brand Team
Development and execution of strategic outcome-based plans for the responsible territory and key accounts
Organization of educational events including monitoring the expense budget for the own territory field activities
Continuous analyses of own market figures including competition and discuss with Sales Manager
Seeks in-depth information from customers to thoroughly understand their needs
Analyzes and shares relevant insights from the field with his/her manager and peers and develops effective ways to deliver on customer feedback and to ensure business growth
Close collaboration with the Sales Manager and the cross-functional team in particular with the Marketing, Medical and Market Access teams
Accountable for targeting & segmentation
Brings up innovative ideas to overcome challenges in the marketplace
Drives omnichannel activities and engage in digital ways of working

Skills

Oncology

Pharmaceutical Sales

Territory Management

Key Account Management

Market Analysis

Product Launch

Customer Insights

Customer Segmentation

Strategic Planning

Cross-functional Collaboration

Educational Events

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free